Company: ENTXW
Filing Date: 2025-03-28
Form Type: 8-K
Source: 0001178913-25-001110
Chunk: 2

Company: Entera Bio Ltd.
Filing Date: 2025-03-28
Form: 8-K
Item: Item 9.01
Chunk 2
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

  Exhibit      Description                                                                                                    
   Number                                                                                                                     
     99.1      Press                                                                                                          
               Release dated March 28, 2025 announcing the Company’s financial results for the year ended December 31, 2024.  
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
      104      Cover Page Interactive Data File (embedded within the Inline XBRL document).                                   

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its
behalf by the undersigned thereunto duly authorized.

                                     ENTERA BIO LTD.                 
  Date: March 28, 2025      By:      /s/ Miranda Toledano            
                                     Name: Miranda Toledano